Skip to main content
. 2022 Dec 1;12(12):e064934. doi: 10.1136/bmjopen-2022-064934

Table 4.

Sexually transmitted infections diagnosed after assault among patients attending a sexual assault centre in Oslo, Norway

Azithromycin prophylaxis recommended
n/N (%)
Azithromycin prophylaxis not recommended
n/N (%)
P value Total
n/N (%)
1. Positive test at primary examination within 2 days of assault.
Infectious agents possibly deposited at assault.
 Genital chlamydia 13/138 (9.4) 21/297 (7.1) 0.51 34/435 (7.8)
Mycoplasma genitalium 8/138 (5.8) 17/228 (7.5) 0.69 25/366 (6.8)
 Gonorrhoea 0/142 4/304 (1.3) 0.31 4/446 (0.9)
 Any of the above 19/142 (13.4)* 36/305 (11.8)* 0.75 55/447 (12.3)*
2. Positive test at primary examination 3–7 days after assault.
Incubation period—infection probably from before assault.
 Genital chlamydia 3/39 (7.7) 8/68 (11.8) 0.74 11/107 (10.3)
M. genitalium 1/38 (2.6) 4/55 (7.3) 0.65 5/93 (5.4)
 Gonorrhoea 0/41 0/68 0/109
 Any of the above 4/41 (9.8) 10/68 (14.7)* 0.65 14/109 (12.8)*
3. Positive test at primary examination 1–4 weeks after assault.
Infection possibly from assault, manifest after incubation.
 Genital chlamydia 1/18 (5.6) 3/36 (8.3) 1.00 4/54 (7.4)
M. genitalium 1/17 (5.9) 1/31 (3.2) 1.00 2/48 (4.2)
 Gonorrhoea 0/19 0/37 0/56
 Any of the above 2/19 (10.5) 3/37 (8.1)* 1.00 5/56 (8.9)*
4. Negative test at primary examination within a week of assault†, positive at follow-up.
Infection possibly from assault.
 Genital chlamydia 1/138 (0.7) 5/289 (1.7) 0.67 6/427 (1.4)
M. genitalium 2/139 (1.4) 7/222 (3.2) 0.49 9/361 (2.5)
 Gonorrhoea 1/162 (0.6) 0/328 0.33 1/490 (0.2)
 Any of the above 4/162 (2.5) 11/333 (3.3)* 0.78 15/495 (3.0)*

*Some patients were infected with more than one agent.

†Two days for gonorrhoea.